Zogenix Inc.

Zogenix Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.26
Market Cap
$2.02 B
Shares Outstanding
42.41 M
Public Float
39.64 M

Profile

Address
5959 Horton Street
Emeryville California 94608
United States
Employees -
Website http://www.zogenix.com
Updated 07/08/2019
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday.

Financials

View All

Stephen J. Farr
President, Chief Executive Officer & Director
Roger L. Hawley
Director